West Pharmaceutical Services (WST) Current Deferred Tax Assets (2009 - 2015)

West Pharmaceutical Services has disclosed Current Deferred Tax Assets across 7 years of filings, most recently posting $8.3 million for Q3 2015.

• Current Deferred Tax Assets for Q3 2015 came in at $8.3 million, down 54.89% year-over-year; the trailing twelve-month figure through Sep 2015 was $8.3 million (down 54.89% YoY), and the FY2014 annual result was $7.8 million, down 50.94% from the prior year.
• Current Deferred Tax Assets came in at $8.3 million for Q3 2015 at West Pharmaceutical Services, up from $8.2 million in the prior quarter.
• In the past five years, Current Deferred Tax Assets ranged from a high of $18.4 million in Q3 2014 to a low of $7.4 million in Q2 2012.
• The 5-year median for Current Deferred Tax Assets is $9.1 million (2013), against an average of $10.7 million.
• Across the five-year window, Current Deferred Tax Assets soared 106.49% in 2013 and sank 54.89% in 2015, its largest moves.
• West Pharmaceutical Services' Current Deferred Tax Assets stood at $7.9 million in 2011, then retreated by 2.53% to $7.7 million in 2012, then surged by 106.49% to $15.9 million in 2013, then tumbled by 50.94% to $7.8 million in 2014, then grew by 6.41% to $8.3 million in 2015.
• The last three Current Deferred Tax Assets figures came in at $8.3 million (Q3 2015), $8.2 million (Q2 2015), and $8.7 million (Q1 2015), per Business Quant data.